To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk cls 1/19 cls
Actelion (SWX:ATLN) ING Bank Mark Clark New Sell 6% CHF273.5
Lehman Peter Welford Price target Overweight
Clark set a CHF220 target. He thinks Tracleer bosentan to treat pulmonary arterial hypertension (PAH) will soon face serious competition from ambrisentan, for which Gilead (GILD) submitted an NDA to FDA last

Read the full 618 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers